$15.900
-0.789 (-4.96%)收盘时
- High
- 16.720
- Open
- 16.700
- VWAP
- 16.11
- Vol
- 105.55K
- Mkt Cap
- 205.55M
- Low
- 15.710
- Amount
- 1.70M
- EV/EBITDA, TTM
- 0.00
SWK Holdings Corporation is a life science focused specialty finance company partnering with small- and mid-sized commercial-stage healthcare companies. The Company provides non-dilutive financing to fuel the development and commercialization of lifesaving and life-enhancing medical technologies and products. The Company's solutions include structured debt, traditional royalty monetization, synthetic royalty transactions, and asset purchases typically ranging in size from $5.0 million to $25.0 million.
AI analysis of SWK Holdings Corp (SWKH)
sellSWK Holdings Corp (SWKH) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company's financial performance is significantly deteriorating, with revenue, net income, and EPS showing sharp declines. Technical indicators suggest a bearish trend, and there are no positive trading signals or catalysts to support a buy decision. Additionally, there is no recent news, analyst ratings, or insider activity to indicate potential upside.
估值指标
事件时间线
资讯
8.503-09Yahoo FinanceRunway Growth Finance Acquires SWK Holdings to Scale Portfolio
7.010-16PRnewswireSHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates SWKH, ETNB, BRNS, VRNT on Behalf of Shareholders
7.010-16GlobenewswireBRODSKY & SMITH INVESTOR ALERT: Updates on Investigations Involving TrueCar, Inc. (Nasdaq – TRUE), Astria Therapeutics, Inc. (Nasdaq – ATXS), PotlatchDeltic Corporation (Nasdaq – PCH), and SWK Holdings Corporation (Nasdaq – SWKH)
4.510-15TipRanksVTI ETF Daily Update: Key Information for Investors – 10/15/2025
7.010-11GlobenewswireSHAREHOLDER RIGHTS NOTICE: Halper Sadeh LLC Probes EA, HSII, SWKH for Shareholder Interests
SWKH FAQ — answered by Alphio AI
SWK Holdings Corporation is a life science focused specialty finance company partnering with small- and mid-sized commercial-stage healthcare companies. The Company provides non-dilutive financing to fuel the development and commercialization of lifesaving and life-enhancing medical technologies and products. The Company's solutions include structured debt, traditional royalty monetization, synthetic royalty transactions, and asset purchases typically ranging in size from $5.0 million to $25.0 million. It operates in the Financials sector (MISCELLANEOUS BUSINESS CREDIT INSTITUTION industry).
SWK Holdings Corp (SWKH) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company's financial performance is significantly deteriorating, with revenue, net income, and EPS showing sharp declines. Technical indicators suggest a bearish trend, and there are no positive trading signals or catalysts to support a buy decision. Additionally, there is no recent news, analyst ratings, or insider activity to indicate potential upside.
本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。